Ablation Device Treats Heavy Menstrual Bleeding
By HospiMedica International staff writers Posted on 06 Sep 2015 |

Image: The Minerva Surgical Endometrial Ablation System (Photo courtesy of Minerva Surgical).
A new endometrial ablation system treats menorrhagia in premenopausal women due to benign causes, and for whom childbearing is complete.
The Minerva Surgical Endometrial Ablation System uses three separate ablation mechanisms to provide a safer and more effective means of treating excessive menstrual bleeding. The system is based on an impedance controlled treatment cycle specific to individual patient conditions. The first ablation step uses bipolar radiofrequency (RF) energy to ablate the endometrium. The second step uses the high voltage RF electrical current to ionize fully contained and circulated argon gas within a plasma formation array (PFA) sealed silicone membrane.
When the stretchable silicone membrane is deployed it conforms to the uterus; once energized, the argon gas is ionized, turning it in to a stream of plasma which heats the interior surface of the silicone membrane. The thermal energy is then conducted uniformly to the tissue in contact with the membrane. In the third step, released intra-cavitary fluids fills the gaps missed in the first two steps and further ablate remaining endometrial tissue. The system integration results in a faster procedure time and improved tissue contact.
Other features of the system include easy insertion, seating, and a non-stick atraumatic removal due to the lubricous nature of the silicone membrane array; a patented uterine integrity test (UIT) that automatically checks the integrity of the uterine cavity including the array membrane; and a cervical sealing balloon that positively seals the cervix canal near the internal os. The Endometrial Ablation System is a product of Minerva Surgical (Redwood City, CA, USA), and has been approved by the US Food and Drug Administration (FDA).
Menorrhagia, described as heavy and prolonged menstrual bleeding which disrupts a woman's normal activities, is one of the most common complaints in gynecology. Bleeding generally lasts for more than a week, requiring women to change their pad or tampon every two hours or less. Women with menorrhagia may also pass large blood clots and experience anemia due to the volume of blood loss. Constant lower abdominal and pelvic pain, tiredness, fatigue, and shortness of breath due to the heavy bleeding are also common.
Related Links:
Minerva Surgical
Minerva video
The Minerva Surgical Endometrial Ablation System uses three separate ablation mechanisms to provide a safer and more effective means of treating excessive menstrual bleeding. The system is based on an impedance controlled treatment cycle specific to individual patient conditions. The first ablation step uses bipolar radiofrequency (RF) energy to ablate the endometrium. The second step uses the high voltage RF electrical current to ionize fully contained and circulated argon gas within a plasma formation array (PFA) sealed silicone membrane.
When the stretchable silicone membrane is deployed it conforms to the uterus; once energized, the argon gas is ionized, turning it in to a stream of plasma which heats the interior surface of the silicone membrane. The thermal energy is then conducted uniformly to the tissue in contact with the membrane. In the third step, released intra-cavitary fluids fills the gaps missed in the first two steps and further ablate remaining endometrial tissue. The system integration results in a faster procedure time and improved tissue contact.
Other features of the system include easy insertion, seating, and a non-stick atraumatic removal due to the lubricous nature of the silicone membrane array; a patented uterine integrity test (UIT) that automatically checks the integrity of the uterine cavity including the array membrane; and a cervical sealing balloon that positively seals the cervix canal near the internal os. The Endometrial Ablation System is a product of Minerva Surgical (Redwood City, CA, USA), and has been approved by the US Food and Drug Administration (FDA).
Menorrhagia, described as heavy and prolonged menstrual bleeding which disrupts a woman's normal activities, is one of the most common complaints in gynecology. Bleeding generally lasts for more than a week, requiring women to change their pad or tampon every two hours or less. Women with menorrhagia may also pass large blood clots and experience anemia due to the volume of blood loss. Constant lower abdominal and pelvic pain, tiredness, fatigue, and shortness of breath due to the heavy bleeding are also common.
Related Links:
Minerva Surgical
Minerva video
Latest Surgical Techniques News
- Breakthrough Polymer Significantly Improves Safety of Implantable Medical Devices
- First-Ever Technology Makes Blood Translucent During Surgery
- Tibia Nailing System with Novel Side-Specific Nails to Revolutionize Fracture Surgery
- New Imaging Probe to Transform Brain Cancer Surgery
- New Technology More Than Doubles Success Rate for Blood Clot Removal
- Surgical Ablation During CABG Improves Survival in Patients with Preexisting Atrial Fibrillation
- New Battery Technology Delivers Additional Power to Implantable Medical Devices
- New Model Reveals Optimal Positioning of Orthopedic Screws in Fractures
- Non-Invasive Tool for Removing Lung Cancer Tumors Reduces Surgical Trauma
- Advanced Imaging Endoscopes to Revolutionize Detection and Treatment of Gastrointestinal Disorders
- Novel Mechanical Heart Valve Improves Blood Flow and Lowers Risk of Blood Clots
- First-of-Its-Kind Device Replaces Mitral Valve Without Open-Heart Surgery
- Innovation in Thermographic Neurosurgical Imaging Supports Informed Decision-Making
- Fluorescent Soft Robots Accurately Locate Early Gastric Cancer During Laparoscopic Surgery
- Ultrasound-Activated Microstructures Clean Implanted Stents and Catheters
- First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment
Channels
Critical Care
view channel
Cuff-Free Blood Pressure Monitoring Device to Improve Early Detection and Management of Hypertension
Hypertension affects nearly half of all adults in the U.S. and remains the leading cause of cardiovascular disease. Regular and accurate blood pressure monitoring is essential for managing this condition,... Read more
New Understanding of Barrett’s Esophagus Formation to Enable Earlier Intervention and Diagnosis
Barrett’s esophagus is a condition in which the lining of the esophagus—normally composed of squamous epithelial cells—undergoes a transformation into cells resembling those found in the stomach or intestine.... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read moreBusiness
view channel
Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more